Financials
- Market Capitalization 28.48 M
- Employee 15
- Founded 2015
- CEO N/A
- Website www.contexttherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG011YW6H86
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.87
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4366 | NXTC NextCure, Inc. - Common Stock | 6.64 USD | -7.52% | +30.97% | +0.76% | -49.31% | 30.39 M USD | ||
| 4382 | IGC IGC Pharma, Inc. Common Stock | 0.28 USD | 0.00% | 0.00% | 0.00% | +9.29% | 28.95 M USD | ||
| 4388 | EDSA Edesa Biotech, Inc. - Common Shares | 2.94 USD | -16.24% | -25.38% | -33.63% | +15.29% | 28.34 M USD | ||
| 4396 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.63 USD | -12.37% | -7.91% | -1.21% | -82.86% | 27.60 M USD |